Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Sharks may hold cancer key

Wednesday 23 April 1997 23:02 BST
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Sharks may provide a means of attacking cancer that is to be tested for the first time in patients later this year. An extract from shark tissue called squalamine, discovered in the stomach of the dog fish, is thought to prevent tumours from growing by cutting off their blood supply.

It was discovered by researchers working for Magainin Pharmaceuticals, a biotechnology company based in Plymouth Meeting, Pennsylvania, USA. Chairman Jay Moorin told New Scientist magazine: "We were looking for antibiotics in the shark tissue but instead we found a whole family of new compounds that stop cells from dividing."

The compounds are believed to act as a primitive immune system in the shark because they kill infectious microbes. Of the 18 compounds discovered, squalamine showed the most promise as an anti-cancer agent. Other substances have shown potential as treatments for Aids.

Trials of the drug are expected to begin in the autumn in patients with brain or breast cancer, New Scientist said. The idea is to use it to prevent a relapse, rather than as a primary treatment.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in